Search Results - "Panchal, Anil Kumar"
-
1
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
Published in International immunopharmacology (01-10-2021)“…•Cross talk between SARS-CoV-2 and Influenza.•HA immunized mice sera poorly or do not cross-react with the RBD of SARS-CoV2.•Cross reactive antibodies in…”
Get full text
Journal Article -
2
A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern
Published in PLoS pathogens (01-12-2022)“…The emergence of new variants of SARS-CoV-2 necessitates unremitting efforts to discover novel therapeutic monoclonal antibodies (mAbs). Here, we report an…”
Get full text
Journal Article -
3
A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single‐chain antibody fragments
Published in Biotechnology progress (01-05-2021)“…Phage display antibody (PDA) libraries, allows the rapid isolation and characterization of high specificity monoclonal antibodies for therapeutic and…”
Get full text
Journal Article -
4
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
Published in International immunopharmacology (01-12-2021)“…•Cross talk between SARS CoV-2 and HIV-1.•Non-neutralizing antibody cross reactivity response connecting SARS CoV-2 and HIV-1.•Cross reactive responses among…”
Get full text
Journal Article